全文获取类型
收费全文 | 996篇 |
免费 | 103篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 22篇 |
妇产科学 | 12篇 |
基础医学 | 115篇 |
口腔科学 | 18篇 |
临床医学 | 98篇 |
内科学 | 182篇 |
皮肤病学 | 4篇 |
神经病学 | 118篇 |
特种医学 | 36篇 |
外国民族医学 | 3篇 |
外科学 | 164篇 |
综合类 | 18篇 |
预防医学 | 125篇 |
眼科学 | 30篇 |
药学 | 85篇 |
中国医学 | 1篇 |
肿瘤学 | 49篇 |
出版年
2023年 | 6篇 |
2022年 | 13篇 |
2021年 | 35篇 |
2020年 | 11篇 |
2019年 | 22篇 |
2018年 | 35篇 |
2017年 | 28篇 |
2016年 | 19篇 |
2015年 | 25篇 |
2014年 | 23篇 |
2013年 | 33篇 |
2012年 | 42篇 |
2011年 | 72篇 |
2010年 | 25篇 |
2009年 | 25篇 |
2008年 | 42篇 |
2007年 | 52篇 |
2006年 | 44篇 |
2005年 | 37篇 |
2004年 | 29篇 |
2003年 | 35篇 |
2002年 | 26篇 |
2001年 | 19篇 |
2000年 | 24篇 |
1999年 | 22篇 |
1998年 | 13篇 |
1997年 | 10篇 |
1996年 | 6篇 |
1995年 | 10篇 |
1994年 | 9篇 |
1993年 | 6篇 |
1992年 | 16篇 |
1991年 | 12篇 |
1990年 | 21篇 |
1989年 | 20篇 |
1988年 | 13篇 |
1987年 | 11篇 |
1986年 | 12篇 |
1985年 | 13篇 |
1984年 | 12篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1976年 | 10篇 |
1974年 | 7篇 |
1973年 | 16篇 |
1971年 | 18篇 |
1969年 | 8篇 |
1968年 | 9篇 |
1967年 | 11篇 |
1966年 | 8篇 |
排序方式: 共有1100条查询结果,搜索用时 23 毫秒
1.
Chronic obstructive pulmonary disease is one of the most significant chronic illnesses of adults. Comprehensive care of the affected patient requires the medical-surgical nurse to have knowledge of the disease process, collaborative management, and nursing care based on research and current practice guidelines. 相似文献
2.
3.
C V Patrick Onyeaka Christos Alexiou Gaetano Rocco David N Hopkinson S Kim Suvarna Peter C Braidley Tim J Locke 《The Journal of heart and lung transplantation》2005,24(8):1140-1142
Transplant pneumonectomy is a rarely performed procedure. It is occasionally carried out in the course of retransplantation. To our knowledge, resection of a transplanted lung without its replacement and with successful outcome in the adult has not been previously reported. We present a case of elective left transplant pneumonectomy in a 38-year-old man 6 years after left single-lung transplant. At 12 months after resection, the patient remains well, with good exercise tolerance. 相似文献
4.
5.
Seven elite boardsailors reporting nonradiating low back pain without leg pain during sailing volunteered for detailed examination. In these subjects, the onset of pain was limited to those occasions when sailing positions were held for a significant period of time, e.g., close hauled sailing or in light winds. No pain was described at any other time. The determination of possible antecedent factors was based on the results of clinical assessment, radiological evaluation, and computer tomography (CT) scanning. Apart from limited flexibility in some subjects, the clinical examination of these athletes was normal; CT changes in this group were limited to disc protrusions and bulges, and pars interarticularis defects. Despite the small number of subjects in the present report, it appears that the frequency of these problems exceeds that in the normal population. It may be possible to suggest that risk factors such as body position during prolonged sailing, particularly under light wind conditions without a harness, and limited flexibility may be associated with the radiological findings and may be implicated in the presence of low back pain, although further investigations appears warranted. 相似文献
6.
Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults 总被引:8,自引:0,他引:8
K A Christie J D Burke D A Regier D S Rae J H Boyd B Z Locke 《The American journal of psychiatry》1988,145(8):971-975
Data from the National Institute of Mental Health (NIMH) Epidemiologic Catchment Area Program, an epidemiologic survey of five communities, showed that four major disorders commonly begin in late adolescence or young adulthood. The median age at onset for anxiety disorders is 15 years; for major depressive episode, 24 years; for drug abuse or dependence, 19 years; and for alcohol abuse or dependence, 21 years. Findings also suggest that for respondents 18-30 years old, having a major depressive episode or anxiety disorder doubles the risk for later drug abuse or dependence. 相似文献
7.
Kenneth W. Locke Robert W. Dunn John W. Hubbard Cheri L. Vanselous Michael Cornfeldt Stuart Fielding Joseph T. Strupczewski 《Drug development research》1990,19(3):239-256
HP 818 (1-benzoyl-6-fluoro-3-(1-methyl-4-piperidinyl)-1H-indazole) exhibits the profile of a potent nonnarcotic analgesic with neuroleptic properties. HP 818 blocks the effects of chemical (phenylquinone), pressure (tail clip), and radiant heat (tail flick) painful stimuli in mice (ED50 values of 0.3, 1.2, and 4.1 mg/kg s.c., respectively). This compound displays antinociceptive activity by the subcutaneous, oral, and intravenous routes of administration. It is also effective in the shock titration assay in squirrel monkeys and in a model of surgically induced pain. The rank order of potency of HP 818 and several other standard compounds in these tests for analgesia was Innovar > fentanyl > HP 818 > codeine > droperidol. In addition to its antinociceptive effects, HP 818 possesses neuroleptic properties. It is active in the climbing mouse, pole climb avoidance, and intracranial self-stimulation assays (ED50 values of 1.8, 1.7, and 2.5 mg/kg i.p., respectively). Moreover, HP 818 inhibits amphetamine- and apomorphine-induced stereotypy, indicative of D2-dopaminergic blocking properties. HP 818, unlike typical neuroleptic agents, does not induce supersensitivity to the effects of apomorphine when administered chronically in mice. In contrast to the clinical standard neuroleptanalgesic Innovar, HP 818 (1.0–3.0 mg/kg i.v.) produces no significant cardiovascular or respiratory changes in the anesthetized dog. Thus, HP 818 is potentially an effective presurgical medication due to its nonnarcotic analgesic activity and sedative neuroleptic effects, along with its lack of limiting cardiorespiratory side effects. 相似文献
8.
9.
Thermogenic mechanisms in brown fat 总被引:25,自引:0,他引:25
10.
David K. C. Cooper Hidetaka Hara Hayato Iwase Takayuki Yamamoto Zheng‐Yu Wang Abhijit Jagdale Mohamed H. Bikhet Huy Q. Nguyen Jeremy B. Foote Wayne D. Paris David Ayares Vineeta Kumar Douglas J. Anderson Jayme E. Locke Devin E. Eckhoff 《Clinical transplantation》2021,35(1):e14139
Pig organ xenotransplantation offers a solution to the shortage of deceased human organs for transplantation. The pathobiological response to a pig xenograft is complex, involving antibody, complement, coagulation, inflammatory, and cellular responses. To overcome these barriers, genetic manipulation of the organ‐source pigs has largely been directed to two major aims—(a) deletion of expression of the known carbohydrate xenoantigens against which humans have natural (preformed) antibodies, and (b) transgenic expression of human protective proteins, for example, complement‐ and coagulation‐regulatory proteins. Conventional (FDA‐approved) immunosuppressive therapy is unsuccessful in preventing an adaptive immune response to pig cells, but blockade of the CD40:CD154 costimulation pathway is successful. Survival of genetically engineered pig kidneys in immunosuppressed nonhuman primates can now be measured in months. Non‐immunological aspects, for example, pig renal function, a hypovolemia syndrome, and rapid growth of the pig kidney after transplantation, are briefly discussed. We suggest that patients on the wait‐list for a deceased human kidney graft who are unlikely to receive one due to long waiting times are those for whom kidney xenotransplantation might first be considered. The potential risk of infection, public attitudes to xenotransplantation, and ethical, regulatory, and financial aspects are briefly addressed. 相似文献